home / stock / dva / dva news


DVA News and Press, DaVita Inc. From 02/11/22

Stock Information

Company Name: DaVita Inc.
Stock Symbol: DVA
Market: NYSE
Website: davita.com

Menu

DVA DVA Quote DVA Short DVA News DVA Articles DVA Message Board
Get DVA Alerts

News, Short Squeeze, Breakout and More Instantly...

DVA - DaVita (DVA) Q4 2021 Earnings Call Transcript

Image source: The Motley Fool. DaVita (NYSE: DVA) Q4 2021 Earnings Call Feb 10, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: DaVita (DVA) Q4 2021 Earnings Call Transcript

DVA - DaVita Inc.'s (DVA) CEO Javier Rodriguez on Q4 2021 Results - Earnings Call Transcript

DaVita Inc.’s (DVA) Q4 2021 Earnings Conference Call February 10, 2022 05:00 PM ET Company Participants Jim Gustafson - Vice President of Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Sarah James - Bar...

DVA - DaVita HealthCare Partners Non-GAAP EPS of $2.02 beats by $0.22, revenue of $2.94B beats by $30M

DaVita HealthCare Partners press release (NYSE:DVA): Q4 Non-GAAP EPS of $2.02 beats by $0.22. Revenue of $2.94B (+1.0% Y/Y) beats by $30M. 2022 Guidance: The company expects Non-GAAP EPS to be in the range of $7.50-$8.50 vs. consensus of $8.22; Free cash flow from continuing operations of $85...

DVA - DaVita Inc. 4th Quarter 2021 Results

DaVita Inc. 4th Quarter 2021 Results PR Newswire DENVER , Feb. 10, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2021. "COVID continues to evolve and have a direct...

DVA - Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022

EDEN PRAIRIE, Minn., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that the Company will ring the closi...

DVA - DaVita Q4 2021 Earnings Preview

DaVita (NYSE:DVA) is scheduled to announce Q4 earnings results on Thursday, Feb. 10, after market close. The consensus EPS estimate is $1.80 and the consensus revenue estimate is $2.91B (flat Y/Y). Over the last 2 years, DVA has beaten EPS estimates 75% of the time and has beaten revenue...

DVA - 3 Warren Buffett Stocks to Buy in February: DaVita, Bristol Myers Squibb, and AbbVie

Warren Buffett’s value investing strategy has paid off, as its investment firm Berkshire Hathaway (BRK.A) has outperformed the broader market. Recently, the billionaire has become worther than Meta Platforms (FB) founder Mark Zuckerberg. Hence, we believe that the Berkshire Hathaway ho...

DVA - DaVita Inc. Schedules 4th Quarter 2021 Investor Conference Call

DaVita Inc. Schedules 4th Quarter 2021 Investor Conference Call PR Newswire DENVER , Jan. 27, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, Febru...

DVA - 5 Top Health Care Stocks To Watch Before February 2022

5 Health Care Stocks For Your February 2022 Watchlist Without question, the global pandemic brought health care stocks to the minds of many investors in the stock market. Nevertheless, investors should find comfort in knowing that the health care sector will remain relevant with or ...

DVA - Kidney Doctors, Transplant Providers Work with DaVita in New Government Program to Help Improve the Lives of Medicare Patients with Kidney Disease

Kidney Doctors, Transplant Providers Work with DaVita in New Government Program to Help Improve the Lives of Medicare Patients with Kidney Disease Programs aim to slow the progression of kidney disease and increase access to home dialysis and kidney transplantation PR Newswi...

Previous 10 Next 10